MARC details
| 000 -LEADER |
|---|
| fixed length control field |
06009nam a2200541 a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
BB25541788 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
StDuBDS |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20231106113705.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr|||||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
141003s2014 ne fs 001|0|eng|d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780124079014 (e-book) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780124080782 (hbk.) : |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Canceled/invalid ISBN |
9780124079014 (PDF ebook) |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
StDuBDS |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
StDuBDS |
| Modifying agency |
StDuBDSZ |
| -- |
UkHlBB |
| 050 #0 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RG627.6.D79 |
| Item number |
D7 2014 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
HEA |
| Source |
ukslc |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MJ |
| Source |
bicssc |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MJT |
| Source |
bicssc |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MMG |
| Source |
bicssc |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
618.32 |
| Edition number |
23 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Drugs during pregnancy and lactation |
| Medium |
[electronic resource] : |
| Remainder of title |
treatment options and risk assessment / |
| Statement of responsibility, etc. |
edited by Christof Schaefer, Paul Peters, and Richard K. Miller. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
Third edition. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Amsterdam : |
| Name of publisher, distributor, etc. |
Academic Press, |
| Date of publication, distribution, etc. |
2014. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
928 pages |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Source |
rdacarrier |
| 366 ## - TRADE AVAILABILITY INFORMATION |
|---|
| Detailed date of publication |
20141009 |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Previous edition: Amsterdam; London: Elsevier, 2007. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
1. General Commentary on drug therapy and drug risks in pregnancy 2. Specific drug therapties during pregnancy 2.1 Analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and antigout medications 2.2 Allergy and hyosensitization therapy 2.3 Antiasthmatic and cough medication 2.4 Nausea and vomiting in pregnancy 2.5 Gastro-intestinal medications, hyoplipidemic agents and spasmolytics 2.6 Anti-infective Agents 2.7 Vaccines and immunoglobulins 2.8 Heart and blood medications 2.9 Anticoagulants, thrombocyte aggregation inhibitors, fibrinolyrics,and volume replacement agents 2.10 Epilepsy and antiepileptic medications 2.11 Psychotropic drugs 2.12 Immunosuppression, rheumatic diseases, multiple sclerosis, and Wilson's disease 2.13 Antineoplastic drugs 2.14 Uterine contraction agents, tocolytics, vaginal therapeutics and local contraceptives 2.15 Hormones 2.16 General and local anesthetics and muscle relaxants 2.17 Dermatological medications and local therapeutics 2.18 Vitamins, minerals and trace elements 2.19 Herbs during pregnancy 2.20 Diagnostic agents 2.21 Recreational drugs 2.22 Poisonings and toxins 2.23 Occupational, industrial and environmental agents 3. General commentary on drug therapy and drug risk during lactation 3.1 The advances of breastfeading versus the risks of maternal medication 3.2 The passage of medication into the mother's milk 3.3 Infant characteristics 3.4 Milk plasma ratio 3.5 Amount of medication in the milk and relative dose 3.6 Toxicity of medications in the mother's milk 3.7 Medications that affect lactation 3.8 Breastfeeding support 4. Specific drug therapies during lactation 4.1 Analgesics, antiphlogistics and anesthetics 4.2 Antiallergics, antiasthmatics and antitussives 4.3 Gastrointestinal drugs 4.4 Anti-infectives 4.5 Vaccines and immunoglobulins 4.6 Cardiovascular drugs and diuretics 4.7 Anticoagulants, thrombocyte aggregation inhibitors and fibrinolytics 4.8 Antiepileptics 4.9 Psychotropic drugs 4.10 Immunomodulating and antineoplastic agents 4.11 Hormones and hormone antagonists 4.12 Dermatological medication and local therapeutics 4.13 Alternative remedies, vitamins, and minerals 4.14 Contrast media, radionuclides and diagnostics 4.15 Infections during breastfeeding 4.16 Recreational drugs 4.17 Plant toxins 4.18 Industrial chemicals and environmental contaminants 4.18.1 Persistent organochlorine compounds (pesticides, polychlorinated biphenyls and dioxins) 4.18.2 Mercury 4.18.3 Lead 4.18.4 Cadmium 4.18.5 Other contaminants 4.18.6 Breasfeeding despite environmental contaminants? 4.18.7 Breastfeeding and the workplace |
| 520 8# - SUMMARY, ETC. |
|---|
| Summary, etc. |
This work presents the state of knowledge about drugs in pregnancy. In each chapter information is presented separately for two different aspects of the problem seeking a drug appropriate for prescription during pregnancy, and assessing the risk of a drug when exposure has already taken place. |
| Expansion of summary note |
Drugs During Pregnancy and Lactation, 3 rd Edition is a quick and reliable reference for all those working in disciplines related to fertility, pregnancy, lactation, child health and human genetics who prescribe or deliver medicinal products, and to those who evaluate health and safety risks. Each chapter contains twofold information regarding drugs that are appropriate for prescription during pregnancy and an assessment of the risk of a drug when exposure during pregnancy has already occurred. Thoroughly updated with current regulations, references to the latest pharmacological data, and new medicinal products, this edition is a comprehensive resource covering latest knowledge and findings related to drugs during lactation and pregnancy. Provides evidence-based recommendations to help clinicians make appropriate recommendations Uniquely organized and structured according to drug class and treatment indications to offer authoritative clinical content on potential adverse effects Highlights new research developments from primary source about working mechanism of substances that cause developmental disorders |
| 530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE |
|---|
| Additional physical form available note |
Also available in printed form ISBN 9780124080782 |
| 533 ## - REPRODUCTION NOTE |
|---|
| Type of reproduction |
Electronic reproduction. |
| Agency responsible for reproduction |
Browns Books For Students. |
| Note about reproduction |
Mode of access: World Wide Web. |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject heading |
Pregnant women |
| General subdivision |
Drug use. |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject heading |
Pregnant women |
| General subdivision |
Medical care. |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject heading |
Obstetrical pharmacology |
| Form subdivision |
Handbooks, manuals, etc. |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject heading |
Fetus |
| Form subdivision |
Handbooks, manuals, etc. |
| General subdivision |
Effect of drugs on |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject heading |
Newborn infants |
| Form subdivision |
Handbooks, manuals, etc. |
| General subdivision |
Effect of drugs on |
| 650 #7 - SUBJECT HEADINGS |
|---|
| Subject heading |
Health and Wellbeing. |
| Source of heading or term |
ukslc |
| 655 #7 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Electronic books. |
| Source of term |
lcsh |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Schaefer, Christof, |
| Relator term |
editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Peters, P. W. J. |
| Relator term |
editor. |
| Fuller form of name |
(Paul W. J.), |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Miller, Richard K. |
| Dates associated with a name |
1946- |
| Relator term |
editor. |
| Fuller form of name |
(Richard Kermit), |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="#gotoholdings">#gotoholdings</a> |
| Link text |
Access resource |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
E-book |
| 997 ## - |
|---|
| -- |
GMEBOOK |
